SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

Home・Aandelen Lijst・Nanobiotix

N
Nanobiotix

Gesloten

19.56 -1.81

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

19.44

Max

19.74

Belangrijke statistieken
By Trading Economics
Inkomsten	41M -5.4M
Verkoop	48M 27M
Winstmarge	-20.208
Werknemers	103
EBITDA	46M 1.1M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+16.63% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	41M 948M
Vorige openingsprijs	21.37
Vorige sluitingsprijs	19.56

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

2.975 / 3.015 Steun & Weerstand

Nanobiotix Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 dec 2025, 21:41 UTC

Acquisities, Fusies, Overnames

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

28 dec 2025, 23:57 UTC

Winsten

'Avatar: Fire and Ash' Tops Domestic Box Office Again -- Barrons.com

28 dec 2025, 23:48 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

28 dec 2025, 23:48 UTC

Marktinformatie

Global Equities Roundup: Market Talk

28 dec 2025, 23:48 UTC

Marktinformatie

Nikkei May Rise on Weaker Yen -- Market Talk

28 dec 2025, 10:30 UTC

Acquisities, Fusies, Overnames

There's No Happy Ending for Movie Theaters, No Matter Who Wins Warner -- Heard on the Street -- WSJ

26 dec 2025, 20:22 UTC

Marktinformatie

Oil Loses Ground On Russia-Ukraine Peace Efforts -- Market Talk

26 dec 2025, 20:13 UTC

Marktinformatie

U.S. Natural Gas Gains on Colder Weather Outlook -- Market Talk

26 dec 2025, 19:24 UTC

Acquisities, Fusies, Overnames

Nvidia's Groq Deal Is an Instagram Moment -- With 1 Big Risk -- Barrons.com

26 dec 2025, 17:45 UTC

Marktinformatie

U.S. Diesel Down on Lower Crude Prices, Freight-Sector Lull -- Market Talk

26 dec 2025, 15:52 UTC

Marktinformatie

Oil Futures Turn Lower After Steady Start -- Market Talk

26 dec 2025, 14:58 UTC

Marktinformatie

Silver, Gold Reach New Highs Amid Geopolitical Tension -- Market Talk

26 dec 2025, 14:41 UTC

Marktinformatie

U.S. Natural Gas Futures Look to End Week Higher -- Market Talk

26 dec 2025, 14:28 UTC

Marktinformatie

Dollar Indexes Flat as Yen Rally Wanes -- Market Talk

26 dec 2025, 13:47 UTC

Marktinformatie

Oil Futures Steady in Thin Holiday Trade -- Market Talk

26 dec 2025, 07:22 UTC

Marktinformatie

Comex Gold Futures' Strong Bullish Momentum in Play, Chart Shows -- Market Talk

26 dec 2025, 05:03 UTC

Marktinformatie

Malaysian Ringgit Likely to Face Pressure From Dollar Strength in 1Q -- Market Talk

26 dec 2025, 03:38 UTC

Marktinformatie

Global Equities Roundup: Market Talk

26 dec 2025, 03:38 UTC

Marktinformatie

Korean Won Strengthens, Supported by Verbal Interventions -- Market Talk

26 dec 2025, 02:44 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

26 dec 2025, 02:44 UTC

Marktinformatie

Singapore Dollar Weakens Slightly on Likely Position Adjustments -- Market Talk

26 dec 2025, 01:39 UTC

Marktinformatie

China's Central Bank Signals Possibility of Easing Policy in Coming Months -- Market Talk

26 dec 2025, 01:14 UTC

Marktinformatie

Oil Edges Higher Amid Geopolitical Tensions -- Market Talk

26 dec 2025, 00:34 UTC

Marktinformatie

Yen Mostly Weakens Amid Risk-on Sentiment -- Market Talk

26 dec 2025, 00:15 UTC

Marktinformatie

Nikkei Gains 0.6%, Led by Tech, Videogame Stocks -- Market Talk

25 dec 2025, 23:42 UTC

Marktinformatie

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 dec 2025, 23:40 UTC

Marktinformatie

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 dec 2025, 00:20 UTC

Acquisities, Fusies, Overnames

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 dec 2025, 21:26 UTC

Acquisities, Fusies, Overnames

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

Peer Vergelijking

Prijswijziging

Nanobiotix Prognose

Koersdoel

By TipRanks

16.63% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 23 EUR 16.63%

Hoogste 25 EUR

Laagste 21 EUR

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Nanobiotix - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Nanobiotix - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

2.975 / 3.015Steun & Weerstand

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.